Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

677 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists.
Gossec L, Dougados M, Phillips C, Hammoudeh M, de Vlam K, Pavelka K, Pham T, Braun J, Sieper J, Olivieri I, van der Heijde D, Collantes E, Stone M, Kvien TK; ASAS (ASsessment in AS international working group). Gossec L, et al. Among authors: kvien tk. Ann Rheum Dis. 2008 Jun;67(6):782-8. doi: 10.1136/ard.2007.080077. Epub 2007 Nov 29. Ann Rheum Dis. 2008. PMID: 18055468 Free PMC article.
Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
Puyraimond-Zemmour D, Etcheto A, Fautrel B, Balanescu A, de Wit M, Heiberg T, Otsa K, Kvien TK, Dougados M, Gossec L. Puyraimond-Zemmour D, et al. Among authors: kvien tk. Arthritis Care Res (Hoboken). 2017 Oct;69(10):1504-1509. doi: 10.1002/acr.23176. Epub 2017 Sep 6. Arthritis Care Res (Hoboken). 2017. PMID: 27998030
The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.
van Vollenhoven RF, Houbiers JG, Buttgereit F, In 't Hout J, Boers M, Leij S, Kvien TK, Dijkmans BA, Szczepański L, Szombati I, Sierakowski S, Miltenburg AM. van Vollenhoven RF, et al. Among authors: kvien tk. Arthritis Rheum. 2010 Feb;62(2):351-8. doi: 10.1002/art.27196. Arthritis Rheum. 2010. PMID: 20112368 Free article. Clinical Trial.
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.
Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, de Wit M, Dijkmans BA, Dougados M, Englbrecht M, Gogus F, Heiberg T, Hernandez C, Kirwan JR, Mola EM, Cerinic MM, Otsa K, Schett G, Scholte-Voshaar M, Sokka T, von Krause G, Wells GA, Kvien TK. Gossec L, et al. Among authors: kvien tk. Ann Rheum Dis. 2011 Jun;70(6):935-42. doi: 10.1136/ard.2010.142901. Ann Rheum Dis. 2011. PMID: 21540201
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.
Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK. Gossec L, et al. Among authors: kvien tk. Ann Rheum Dis. 2009 Nov;68(11):1680-5. doi: 10.1136/ard.2008.100271. Epub 2008 Dec 3. Ann Rheum Dis. 2009. PMID: 19054825
677 results